Jordan Elm

4.0k total citations · 2 hit papers
51 papers, 2.2k citations indexed

About

Jordan Elm is a scholar working on Epidemiology, Neurology and Psychiatry and Mental health. According to data from OpenAlex, Jordan Elm has authored 51 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 14 papers in Neurology and 10 papers in Psychiatry and Mental health. Recurrent topics in Jordan Elm's work include Acute Ischemic Stroke Management (20 papers), Traumatic Brain Injury and Neurovascular Disturbances (10 papers) and Epilepsy research and treatment (9 papers). Jordan Elm is often cited by papers focused on Acute Ischemic Stroke Management (20 papers), Traumatic Brain Injury and Neurovascular Disturbances (10 papers) and Epilepsy research and treatment (9 papers). Jordan Elm collaborates with scholars based in United States, Canada and United Kingdom. Jordan Elm's co-authors include Joseph P. Broderick, Opeolu Adeoye, W. Taylor Kimberly, Jason T. Connor, Robert Silbergleit, Robin Conwit, Leonardo Bonilha, William G. Barsan, James M. Chamberlain and Jaideep Kapur and has published in prestigious journals such as New England Journal of Medicine, Neurology and Stroke.

In The Last Decade

Jordan Elm

46 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evolution of the Modified Rankin Scale and Its Use in Future Stroke Trials

2017 475 citations Joseph P. Broderick, Opeolu Adeoye et al. Stroke profile →
Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus

2019 305 citations Jaideep Kapur, Jordan Elm et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jordan Elm United States	23	904	609	495	408	352	51	2.2k
Jakob Reith Denmark	18	1.1k 1.2×	829 1.4×	386 0.8×	363 0.9×	191 0.5×	24	2.9k
Keun‐Sik Hong South Korea	38	2.1k 2.3×	966 1.6×	680 1.4×	583 1.4×	375 1.1×	171	4.5k
Jae‐Sung Lim South Korea	27	589 0.7×	437 0.7×	467 0.9×	162 0.4×	83 0.2×	152	2.2k
Mehmet Akif Topçuoğlu Türkiye	31	1.0k 1.1×	1.4k 2.4×	788 1.6×	138 0.3×	215 0.6×	208	3.5k
Κonstantinos Vadikolias Greece	28	705 0.8×	553 0.9×	334 0.7×	187 0.5×	105 0.3×	134	2.3k
Mary D. King Ireland	31	459 0.5×	531 0.9×	706 1.4×	322 0.8×	383 1.1×	90	3.1k
Gerhard J. Jungehülsing Germany	25	1.1k 1.2×	508 0.8×	141 0.3×	426 1.0×	82 0.2×	67	2.3k
Jan Brøgger Norway	24	494 0.5×	249 0.4×	433 0.9×	314 0.8×	179 0.5×	51	1.8k
Eduardo Martínez‐Vila Spain	28	847 0.9×	449 0.7×	302 0.6×	279 0.7×	60 0.2×	114	2.6k
Lars Peter Kammersgaard Denmark	21	1.2k 1.3×	640 1.1×	237 0.5×	597 1.5×	111 0.3×	33	2.1k

Countries citing papers authored by Jordan Elm

Since Specialization

Citations

This map shows the geographic impact of Jordan Elm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jordan Elm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jordan Elm more than expected).

Fields of papers citing papers by Jordan Elm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jordan Elm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jordan Elm. The network helps show where Jordan Elm may publish in the future.

Co-authorship network of co-authors of Jordan Elm

This figure shows the co-authorship network connecting the top 25 collaborators of Jordan Elm. A scholar is included among the top collaborators of Jordan Elm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jordan Elm. Jordan Elm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kamel, Hooman, Mitchell S.V. Elkind, Richard A. Kronmal, et al.. (2025). Heart Rhythm Monitoring Practices, Detection of Atrial Fibrillation, and Effect of Anticoagulation in the ARCADIA Trial. Journal of the American Heart Association. 14(15). e040301–e040301. 1 indexed citations

Cassarly, Christy, Alexandra Basilakos, Lisa Johnson, et al.. (2024). TEleRehabilitation foR Aphasia (TERRA) phase II trial design. Contemporary Clinical Trials Communications. 42. 101406–101406.

Kamel, Hooman, José I. Suárez, E. Sander Connolly, et al.. (2024). Addressing the Evidence Gap in Aneurysmal Subarachnoid Hemorrhage: The Need for a Pragmatic Randomized Trial Platform. Stroke. 55(9). 2397–2400. 1 indexed citations

Lorenzi, Elizabeth, Craig S. Anderson, Bijoy K. Menon, et al.. (2024). Adaptive Platform Trials in Stroke. Stroke. 56(1). 198–208. 3 indexed citations

Chamberlain, James M., Jaideep Kapur, Robert Silbergleit, et al.. (2023). Desirability of Outcome Ranking for Status Epilepticus. Neurology. 101(16). e1633–e1639. 4 indexed citations

Zhao, Wenle, Sharon D. Yeatts, Joseph P. Broderick, et al.. (2023). Optimal Randomization Designs for Large Multicenter Clinical Trials: From the National Institutes of Health Stroke Trials Network Funded by National Institutes of Health/National Institute of Neurological Disorders and Stroke Experience. Stroke. 54(7). 1909–1919. 3 indexed citations

Coles, Lisa D., Eric S. Rosenthal, Thomas P. Bleck, et al.. (2023). Why ketamine. Epilepsy & Behavior. 141. 109066–109066. 8 indexed citations

Lench, Daniel H., Travis H. Turner, Heather A. Boger, et al.. (2023). Multi-session transcutaneous auricular vagus nerve stimulation for Parkinson's disease: evaluating feasibility, safety, and preliminary efficacy. Frontiers in Neurology. 14. 1210103–1210103. 20 indexed citations

Sathe, Abhishek G., Ellen Underwood, Lisa D. Coles, et al.. (2021). Patterns of benzodiazepine underdosing in the Established Status Epilepticus Treatment Trial. Epilepsia. 62(3). 795–806. 52 indexed citations

10.

Kamel, Hooman, Mary Farrant, J. Donald Easton, et al.. (2021). Newly Diagnosed Atrial Fibrillation After Transient Ischemic Attack Versus Minor Ischemic Stroke in the POINT Trial. Journal of the American Heart Association. 10(6). e019362–e019362. 2 indexed citations

11.

Cassarly, Christy, et al.. (2021). Speech Entrainment for Aphasia Recovery (SpARc) phase II trial design. Contemporary Clinical Trials Communications. 24. 100876–100876. 3 indexed citations

12.

Cock, Hannah R., Lisa D. Coles, Jordan Elm, et al.. (2019). Lessons from the Established Status Epilepticus Treatment Trial. Epilepsy & Behavior. 101(Pt B). 106296–106296. 11 indexed citations

13.

Park, Yeonhee, Heather J. Fullerton, & Jordan Elm. (2019). A pragmatic, adaptive clinical trial design for a rare disease: The FOcal Cerebral Arteriopathy Steroid (FOCAS) trial. Contemporary Clinical Trials. 86. 105852–105852. 16 indexed citations

14.

Fridriksson, Julius, Jordan Elm, Brielle C. Stark, et al.. (2018). BDNF genotype and tDCS interaction in aphasia treatment. Brain stimulation. 11(6). 1276–1281. 57 indexed citations

15.

Chaisinanunkul, Napasri, Opeolu Adeoye, Roger Lewis, et al.. (2015). Adopting a Patient-Centered Approach to Primary Outcome Analysis of Acute Stroke Trials Using a Utility-Weighted Modified Rankin Scale. Stroke. 46(8). 2238–2243. 133 indexed citations

16.

Sheth, Kevin N., Jordan Elm, Lauren A. Beslow, Gordon Sze, & W. Taylor Kimberly. (2015). Glyburide Advantage in Malignant Edema and Stroke (GAMES-RP) Trial: Rationale and Design. Neurocritical Care. 24(1). 132–139. 41 indexed citations

17.

Sheth, Kevin N., W. Taylor Kimberly, Jordan Elm, et al.. (2014). Exploratory Analysis of Glyburide as a Novel Therapy for Preventing Brain Swelling. Neurocritical Care. 21(1). 43–51. 39 indexed citations

18.

Elm, Jordan, Yuko Y. Palesch, J. Donald Easton, et al.. (2014). Screen failure data in clinical trials: Are screening logs worth it?. Clinical Trials. 11(4). 467–472. 22 indexed citations

19.

Yoo, Albert J., Kevin N. Sheth, W. Taylor Kimberly, et al.. (2012). Validating Imaging Biomarkers of Cerebral Edema in Patients With Severe Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases. 22(6). 742–749. 42 indexed citations

20.

Meurer, William J., Danilo A. Tagle, Michael D. Fetters, et al.. (2012). An Overview of the Adaptive Designs Accelerating Promising Trials Into Treatments (ADAPT-IT) Project. Annals of Emergency Medicine. 60(4). 451–457. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact